| ²é¿´: 434 | »Ø¸´: 2 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
sundy93½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Çó´óÉñ·Òë
|
|
|
TA is the ratio of the fraction of the dose reaching the target sites, if the dose is administered as drug-carrier conjugate (in our case drug carriers are liposomes), to the fraction of the dose which reaches the same sites if an equal dose of active drug is administered intravenously. |
» ²ÂÄãϲ»¶
307·Ö²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏר˶283Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¼ÆËã»ú11408£¬286·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬085600£¬344·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¿¼Ñе÷¼ÁÉúѰÕÒµ¼Ê¦
ÒѾÓÐ3È˻ظ´
²ÄÁÏ0856 Ó¢Ò»Êý¶þ 323 Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
»¯Ñ§0703-Ò»Ö¾Ô¸211-338·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
sundy93
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 668.5
- É¢½ð: 169
- ºì»¨: 2
- Ìû×Ó: 241
- ÔÚÏß: 79.1Сʱ
- ³æºÅ: 3007229
- ×¢²á: 2014-03-01
- רҵ: Ò©¼Áѧ
3Â¥2015-09-19 19:29:27
jiangguofeng
½ð³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 248
- Ó¦Öú: 41 (СѧÉú)
- ½ð±Ò: 25958.4
- ºì»¨: 25
- Ìû×Ó: 2114
- ÔÚÏß: 567.1Сʱ
- ³æºÅ: 72410
- ×¢²á: 2005-06-04
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2015-09-19 12:46:10














»Ø¸´´ËÂ¥